Why United States Antimony Stock Is Crashing Today
U.S. Antimony (NYSE: UAMY) fell 23.5% by 11:44 a.m. ET after reporting Q2 2026 results. The company posted Q2 2026 revenue of $7.9M, down 24.8% year over year and below analysts’ $21.7M estimate. It cut 2026 revenue guidance to $65M-$75M from $125M and H.C. Wainwright lowered its price target to $9.25 from $11.75.
How this was made
The 30-second read
Why it matters
The immediate trading impact comes from (1) Q2 revenue far below expectations and (2) a substantial reduction in 2026 revenue guidance, both attributed to lower antimony selling prices.
Market read
Traders are reacting to a post-close earnings and guidance reset tied to a steep decline in antimony spot prices.
What to watch
The piece does not quantify cash flow, balance-sheet resilience, or cost structure, which could materially affect how much guidance cuts translate into longer-term risk.
Background
U.S. Antimony reported Q2 2026 results after the close and the article frames the move as commodity-price driven weakness.
Ticker impact
U.S. Antimony shares are down 23.5% after Q2 results missed revenue expectations and management cut 2026 guidance to $65M-$75M.
Near-term downside risk remains elevated until investors gain confidence that antimony pricing stabilizes and guidance is achievable.
The article cites both the Q2 revenue miss versus expectations and a large reduction in 2026 revenue guidance, with explicit linkage to spot price declines.
Market effects
Reinforces commodity-price sensitivity for antimony/mining equities, potentially pressuring peers with similar exposure to spot pricing.
Limited direct regional spillover implied; the catalyst is company-specific guidance tied to commodity prices.
Highlights global antimony price weakness as a driver of earnings and guidance across the supply chain.
Counterpoint
The article argues the company reported no 'devastating' issue beyond commodity-driven weakness, implying valuation could be attractive if antimony prices mean-revert.
Key entities
- public_companyUnited States Antimony
Subject of the article; Q2 results missed expectations and 2026 revenue guidance was cut.
- analyst_firmH.C. Wainwright
Downwardly revised its price target on U.S. Antimony to $9.25 from $11.75.
